Drug discovery

Trophy
#AI #Cancer research #Drug discovery #Nebius #Protein targets #Transcriptomics

Nebius accelerates next generation of AI discovery innovation

DDW’s Megan Thomas attended Nebius’ inaugural AI Discovery Awards in Amsterdam, where top prizes of $100,000 in GPU credits were awarded to four companies pioneering AI breakthroughs in cancer prediction, protein targeting, transcriptomic mapping, and precision diagnostics. The winners were selected from 257 global applications by a panel of 19… Read More

#News

#Drug development #Drug discovery #Meet the Researcher

What are the top books for life sciences researchers?

Both online and in the DDW quarterly magazine, DDW editors interview industry researchers to shine a spotlight on their work in a feature called Meet the Researcher. A question often included is: If you could make everyone read one book, article or academic paper, what would it be and… Read More

#Exclusive Content #Opinion

#DDW Turning Science into Business Symposium #Drug development #Drug discovery #Events

Secure your spot for the DDW Symposium

Register your interest for the DDW Turning Science into Business Symposium, which will take place at the Francis Crick Institute, one of Europe’s biggest biomedical labs, in London, UK in the afternoon on 4 November 2025. The half day event boasts a stellar line… Read More

#News

Ultrasonic microfluidic device
#Drug discovery #Microfluidics #Regenerative Medicine #University of Queensland

‘Smart’ microgel droplets support regenerative medicine research

Australian researchers have patented a new microfluidics tool that produces ‘smart’ microgel droplets for exploring regenerative medicines.  The platform was created by Dr Ruirui Qiao and her team at UQ’s Australian Institute for Bioengineering and Nanotechnology (AIBN).  Dr Qiao said her team’s UQ-Surf microfludics platform… Read More

#News

#Alzheimer's #Cellular imaging #Drug discovery #Imaging #Japan #Nanobodies #Neuroscience

Nanobody-based 3D imaging boosts neuroscience research

Scientists have created a nanobody-based method that enables ultra-fast, high-resolution 3D mapping of neurons and glia in thick brain tissues.  The researchers from Japan have developed a fast, high-sensitivity three dimensional immunohistochemistry (3D-IHC) method using nanobodies fused with peroxidase and a novel signal amplification system.  … Read More

#News

#Drug discovery #eBook #Monoclonal antibodies #Therapeutic Antibodies

The significance of mAbs in drug discovery and development

Monoclonal antibodies (mAbs), thanks to their low toxicity and high specificity, have enjoyed incredible market success across a range of disease categories. This eBook, sponsored by Evotec, examines the challenges, solutions and successes in mAb discovery and development. Download this exclusive eBook to learn more about: The 2025 scientific breakthroughs… Read More

#DDW eBooks #Intelligence

#Drug discovery

Ebook: The significance of mAbs in drug discovery and development

Monoclonal antibodies (mAbs), thanks to their low toxicity and high specificity, have enjoyed incredible market success across a range of disease categories. This eBook, sponsored by Evotec, examines the challenges, solutions and successes in mAb discovery and development. Download this exclusive eBook to learn more about: The 2025 scientific… Read More

#DDW eBooks

#Artificial intelligence (AI) #Drug discovery #Events #Webinar

Last chance to register: How is AI innovating in drug discovery?

Hosted by Drug Discovery World and sponsored by Benchling, this free webinar will explore the impact of AI on drug discovery innovation. Taking place on 26 June, the webinar will see AI experts and leaders discuss where innovation is occurring and what the challenges are to overcome in… Read More

Webinar date:
Sponsored by Benchling
#News

#Drug discovery #Financing #Non-animal model (NAM) #Organoids #Parallel Bio

Parallel Bio secures $21m to advance human-first drug discovery

Biotech company Parallel Bio has raised $21 million in a Series A funding led by AIX Ventures.   The round attracted new investors Amplo and Marc Benioff, founder and CEO of Salesforce, and existing investors Metaplanet, Humba Ventures, Atypical Ventures, Undeterred Capital, and Jeff Dean.   Robert… Read More

#Business & Investment #News

Researcher in a medical lab
#Contract Research Organisations (CROs) #Drug discovery #In vitro assays #Toxicology

CN Bio introduces cross-species DILI services

CN Bio has introduced two new animal microphysiological system (MPS) models to its contract research services (CRS) that it hopes will enhance translatability in preclinical drug safety and toxicology assessments.  Building upon its drug induced liver injury (DILI) assay, the company says the expanded offering enables rapid,… Read More

#Business & Investment #News

Organ-on-a-chip
#Drug discovery #Emulate #High throughput screening #Organ-on-a-chip

Emulate launches unique high-throughput organ-chip platform

Emulate has launched the AVA Emulation System, a self-contained instrument that cultures, incubates, and images up to 96 independent organ-chip samples in a single run.   The company says that AVA delivers an unprecedented magnitude of in vivo-level insights faster than animal models while cutting consumable… Read More

#News

Antibodies
#Antibody drug conjugate (ADC) #Antibody-dependent cellular cytotoxicity #Case study #Drug discovery #Flow Cytometry

Case Study: ADC synthesis, development, and characterisation

A new Case Study is now available from Eurofins Discovery entitled ‘Synthesis & characterization of trastuzumab-based ADCs using fluorescent & cytotoxic payloads‘. Delve into these case studies on ADC synthesis, development, and characterisation, where we reveal how: Trastuzumab-based ADCs with multiple payload linkers demonstrated specific, targeted functional activity. Flow… Read More

#News

#Antibody drug conjugate (ADC) #Antibody-dependent cellular cytotoxicity #Drug discovery #Flow Cytometry

Synthesis & characterisation of trastuzumab-based ADCs using fluorescent & cytotoxic payloads

Delve into these case studies on ADC synthesis, development, and characterisation, where we reveal how: Trastuzumab-based ADCs with multiple payload linkers demonstrated specific, targeted functional activity. Flow cytometry and internalisation assays confirmed antigen targeting and cellular uptake. Cytotoxicity assays revealed nanomolar IC50s only in HER2+ cell lines, confirming ADC efficacy… Read More

#Resources

AI
#Artificial intelligence (AI) #Drug discovery #Events #Webinar

Webinar: How is AI innovating in drug discovery?

Hosted by Drug Discovery World and sponsored by Benchling, this free webinar will explore the impact of AI on drug discovery innovation. Taking place on 26 June, the webinar will see AI experts and leaders discuss where innovation is occurring and what the challenges are to overcome in… Read More

Webinar date:
Sponsored by Benchling
#News

Chained to fibromyalgia concept
#Chronic pain #Drug discovery #Fibromyalgia #Medicinal cannabis #Painkillers

Where are the new drugs for fibromyalgia?

DDW’s Diana Spencer reviews the latest research into fibromyalgia treatment and the new therapies currently in development.  With no existing cure for fibromyalgia, a chronic pain syndrome, current treatments focus on managing the symptoms like pain, fatigue and poor sleep, with exercise being a key part of… Read More

#Exclusive Content

#Cancer research #Drug discovery #Events #Oncology #Webinar

Webinar: Latest developments in cancer research

This free webinar at 3pm BST on 12 June, hosted by DDW and sponsored by Scale Biosciences, will see experts and thought-leaders from the cancer research sector discuss where innovation is occurring and what the challenges are to overcome for drug discovery projects in the oncology field. … Read More

Webinar date:
Sponsored by Scale Biosciences
#News